HSRx 431

Drug Profile

HSRx 431

Alternative Names: HSRx 431; HSRx431

Latest Information Update: 02 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator HerbalScience Group
  • Developer HSRx Biopharmaceutical
  • Class Antivirals
  • Mechanism of Action Virus internalisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Chikungunya virus infections; Zika virus infection
  • Preclinical Dengue

Most Recent Events

  • 02 Dec 2016 Phase-I clinical trials in Chikungunya virus infections (PO)
  • 02 Dec 2016 Phase-I clinical trials in Zika virus infection (PO)
  • 06 Sep 2016 Preclinical trials in Chikungunya virus infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top